What is she best known for?
The fields of study she is best known for:
- Surgery
- Internal medicine
- Cancer
Her primary areas of investigation include Surgery, Internal medicine, Retrospective cohort study, Incidence and Epidemiology.
Her Surgery research is multidisciplinary, incorporating elements of Cause of death and Risk factor.
As part of her studies on Internal medicine, she often connects relevant subjects like Gastroenterology.
Cathy D. Schleck combines subjects such as Crohn's disease, Receiver operating characteristic, Infliximab and Medical record with her study of Retrospective cohort study.
Her Incidence research incorporates themes from Odds ratio, Natural history, Common Terminology Criteria for Adverse Events and Biopsy.
Her studies in Epidemiology integrate themes in fields like Esophagus and Etiology.
Her most cited work include:
- The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients (793 citations)
- Dyspepsia and dyspepsia subgroups: A population-based study (691 citations)
- The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. (504 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Surgery, Internal medicine, Arthroplasty, Gastroenterology and Retrospective cohort study.
She interconnects Osteoarthritis, Incidence and Confidence interval in the investigation of issues within Surgery.
Her research in Incidence intersects with topics in Rochester Epidemiology Project and Risk factor.
Her studies deal with areas such as Rotator cuff, Orthopedic surgery, Implant, Range of motion and Shoulder joint as well as Arthroplasty.
Her Retrospective cohort study study frequently links to related topics such as Complication.
Cathy D. Schleck has included themes like Eosinophilic esophagitis and Pediatrics in her Epidemiology study.
She most often published in these fields:
- Surgery (39.88%)
- Internal medicine (34.23%)
- Arthroplasty (17.26%)
What were the highlights of her more recent work (between 2014-2021)?
- Surgery (39.88%)
- Internal medicine (34.23%)
- Arthroplasty (17.26%)
In recent papers she was focusing on the following fields of study:
Surgery, Internal medicine, Arthroplasty, Physical therapy and Gastroenterology are her primary areas of study.
Her Hazard ratio research extends to Surgery, which is thematically connected.
Her study looks at the intersection of Internal medicine and topics like Placebo with Escitalopram.
Cathy D. Schleck works mostly in the field of Arthroplasty, limiting it down to concerns involving Shoulders and, occasionally, Survivorship curve and Radiography.
Her Physical therapy research includes themes of Orthopedic surgery, Total hip arthroplasty and Cohort.
Her Gastroenterology research also works with subjects such as
- Barrett's esophagus and related Esophagus and General surgery,
- Endoscopy, which have a strong connection to Intestinal metaplasia and Population based study.
Between 2014 and 2021, her most popular works were:
- Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. (153 citations)
- Temporal Trends in the Incidence and Natural History of Diverticulitis: A Population-Based Study (114 citations)
- Shoulder arthroplasty in patients younger than 50 years: minimum 20-year follow-up. (65 citations)
In her most recent research, the most cited papers focused on:
- Surgery
- Internal medicine
- Cancer
Cathy D. Schleck mostly deals with Surgery, Arthroplasty, Retrospective cohort study, Internal medicine and Shoulders.
Her work in Surgery tackles topics such as Hazard ratio which are related to areas like Body mass index.
Cathy D. Schleck combines subjects such as Osteoarthritis and Implant with her study of Arthroplasty.
Her Retrospective cohort study study integrates concerns from other disciplines, such as Pneumothorax, Adverse effect, Hematoma and Liver biopsy.
Her Internal medicine research includes elements of Gastroenterology and Escitalopram.
As part of one scientific family, Cathy D. Schleck deals mainly with the area of Cohort study, narrowing it down to issues related to the GERD, and often Physical therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
